Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 9 of 9 descriptions
No. | 薬物名(臨床試験情報から抽出) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Leflunomide | 1件: Leflunomide Leflunomide | 1件: Leflunomide
Leflunomide
💬1. Leflunomide
| 1件: DHODH DHODH 💬1. Leflunomide
| 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 12件: 11 11, 40, 46, 49, 53, 66, 107, 162, 224, 270, 271, 300 💬1. Leflunomide
| |||||||||||||||||||||||||||||||||||||||||||||||
2 | Leflunomide (permitted, not necessary) | 1件: Leflunomide Leflunomide | 1件: Leflunomide
Leflunomide
💬2. Leflunomide (permitted, not necessary)
| 1件: DHODH DHODH 💬2. Leflunomide (permitted, not necessary)
| 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 46 46 💬2. Leflunomide (permitted, not necessary)
| |||||||||||||||||||||||||||||||||||||||||||||||
3 | Leflunomide 20 mg Tablets (Geneva Pharmaceutical) | 1件: Leflunomide Leflunomide | 1件: Leflunomide
Leflunomide
💬3. Leflunomide 20 mg Tablets (Geneva Pharmaceutical)
| 1件: DHODH DHODH 💬3. Leflunomide 20 mg Tablets (Geneva Pharmaceutical)
| 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 46 46 💬3. Leflunomide 20 mg Tablets (Geneva Pharmaceutical)
| |||||||||||||||||||||||||||||||||||||||||||||||
4 | Leflunomide 20 mg+prednisone 0.5mg/kg/d | 2件: Leflunomide Leflunomide,Prednisone | 2件: Prednisone
Prednisone
,Leflunomide 💬 4. Leflunomide 20 mg+prednisone 0.5mg/kg/d
| 2件: DHODH DHODH,NR3C1 💬 | 4件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidine metabolism 💬 4件: Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidi ... | 1件: 66 66 💬4. Leflunomide 20 mg+prednisone 0.5mg/kg/d
| |||||||||||||||||||||||||||||||||||||||||||||||
5 | Leflunomide 20Mg Tab | 1件: Leflunomide Leflunomide | 1件: Leflunomide
Leflunomide
💬5. Leflunomide 20Mg Tab
| 1件: DHODH DHODH 💬5. Leflunomide 20Mg Tab
| 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 46 46 💬5. Leflunomide 20Mg Tab
| |||||||||||||||||||||||||||||||||||||||||||||||
6 | Leflunomide 20mg/d | 1件: Leflunomide Leflunomide | 1件: Leflunomide
Leflunomide
💬6. Leflunomide 20mg/d
| 1件: DHODH DHODH 💬6. Leflunomide 20mg/d
| 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 53 53 💬6. Leflunomide 20mg/d
| |||||||||||||||||||||||||||||||||||||||||||||||
7 | Leflunomide Mylan | 1件: Leflunomide Leflunomide | 1件: Leflunomide
Leflunomide
💬7. Leflunomide Mylan
| 1件: DHODH DHODH 💬7. Leflunomide Mylan
| 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 53 53 💬7. Leflunomide Mylan
| |||||||||||||||||||||||||||||||||||||||||||||||
8 | Leflunomide(LEF) | 1件: Leflunomide Leflunomide | 1件: Leflunomide
Leflunomide
💬8. Leflunomide(LEF)
| 1件: DHODH DHODH 💬8. Leflunomide(LEF)
| 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 224 224 💬8. Leflunomide(LEF)
| |||||||||||||||||||||||||||||||||||||||||||||||
9 | Leflunomide-Sulfasalazine-Hydroxychloroquine | 3件: Hydroxychloroquine Hydroxychloroquine,Leflunomide, Sulfasalazine | 3件: Sulfasalazine
Sulfasalazine
,Leflunomide , Hydroxychloroquine 💬 9. Leflunomide-Sulfasalazine-Hydroxychloroquine
| 1件: DHODH DHODH 💬9. Leflunomide-Sulfasalazine-Hydroxychloroquine
| 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 46 46 💬9. Leflunomide-Sulfasalazine-Hydroxychloroquine
|